• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.关于《FDA批准的抗脓肿分枝杆菌和龟分枝杆菌药物的抗菌活性鉴定》的评论
J Antimicrob Chemother. 2012 Jan;67(1):252-3. doi: 10.1093/jac/dkr418. Epub 2011 Oct 7.
2
Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.鉴定美国食品和药物管理局批准的用于治疗脓肿分枝杆菌和溃疡分枝杆菌的药物的抗菌活性。
J Antimicrob Chemother. 2011 Jul;66(7):1533-6. doi: 10.1093/jac/dkr154. Epub 2011 Apr 11.
3
Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates.韩国龟分枝杆菌-脓肿分枝杆菌菌群分离株中马赛分枝杆菌和博列特分枝杆菌菌株的比例。
J Clin Microbiol. 2008 Oct;46(10):3384-90. doi: 10.1128/JCM.00319-08. Epub 2008 Aug 27.
4
[Comparative studies on in vitro activities of important antituberculous drugs].
Kekkaku. 1986 May;61(5):285-92.
5
GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.GM-CSF 敲除小鼠用于抗脓肿分枝杆菌活性药物的临床前测试。
J Antimicrob Chemother. 2014 Apr;69(4):1057-64. doi: 10.1093/jac/dkt451. Epub 2013 Nov 11.
6
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].[龟分枝杆菌和脓肿分枝杆菌的药敏分析及Etest药敏试验评估]
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Aug;36(8):567-71.
7
In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
J Med Assoc Thai. 1990 Aug;73(8):438-42.
8
In vivo veritas: the search for TB drug targets goes live.
Nat Med. 2000 Dec;6(12):1330-3. doi: 10.1038/82142.
9
Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.基于表型筛选的抗结核分枝杆菌药物发现策略。
J Antibiot (Tokyo). 2019 Oct;72(10):719-728. doi: 10.1038/s41429-019-0205-9. Epub 2019 Jul 11.
10
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.孔蛋白在耻垢分枝杆菌和龟分枝杆菌对醛类消毒剂及药物敏感性中的作用
Antimicrob Agents Chemother. 2009 Sep;53(9):4015-8. doi: 10.1128/AAC.00590-09. Epub 2009 Jul 6.

引用本文的文献

1
Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in Mycobacterium abscessus.外排泵和膜通透性促成脓肿分枝杆菌的固有抗生素耐药性。
PLoS Pathog. 2025 Apr 10;21(4):e1013027. doi: 10.1371/journal.ppat.1013027. eCollection 2025 Apr.
2
A Simple In Vitro Method to Determine Bactericidal Activity Against Under Hypoxic Conditions.一种在缺氧条件下测定杀菌活性的简单体外方法。
Antibiotics (Basel). 2025 Mar 13;14(3):299. doi: 10.3390/antibiotics14030299.
3
Deep learning-based prediction of chemical accumulation in a pathogenic mycobacterium.基于深度学习的致病性分枝杆菌化学物质积累预测
bioRxiv. 2024 Dec 16:2024.12.15.628588. doi: 10.1101/2024.12.15.628588.
4
Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in .外排泵和膜通透性导致了……的固有抗生素耐药性。 （原句中“in”后面缺少具体内容）
bioRxiv. 2024 Aug 24:2024.08.23.609441. doi: 10.1101/2024.08.23.609441.
5
Activity of Drug Combinations against Grown in Aerobic and Hypoxic Conditions.药物组合在需氧和缺氧条件下对生长的活性。 （你提供的原文似乎不太完整或表述不太准确，正常来说应该是针对某种生物或细胞等在相应条件下生长时药物组合的活性情况 ）
Microorganisms. 2022 Jul 14;10(7):1421. doi: 10.3390/microorganisms10071421.
6
Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.抗分枝杆菌小分子药物研发管道：再利用药物和有前途的新型化学实体。
Med Res Rev. 2021 Jul;41(4):2350-2387. doi: 10.1002/med.21798. Epub 2021 Mar 1.
7
Rifabutin Is Active against Mycobacterium abscessus Complex.利福布汀对脓肿分枝杆菌复合群有活性。
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00155-17. Print 2017 Jun.
8
Mycobacterium chelonae cutaneous infection in a patient with mixed connective tissue disease.一名混合性结缔组织病患者的龟分枝杆菌皮肤感染。
An Bras Dermatol. 2015 Jan-Feb;90(1):104-7. doi: 10.1590/abd1806-4841.20152276.

本文引用的文献

1
Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.鉴定美国食品和药物管理局批准的用于治疗脓肿分枝杆菌和溃疡分枝杆菌的药物的抗菌活性。
J Antimicrob Chemother. 2011 Jul;66(7):1533-6. doi: 10.1093/jac/dkr154. Epub 2011 Apr 11.
2
Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry.基质辅助激光解吸电离飞行时间质谱法鉴定固体培养介质中的分枝杆菌。
J Clin Microbiol. 2011 May;49(5):1790-4. doi: 10.1128/JCM.02135-10. Epub 2011 Mar 16.
3
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.美国胸科学会/美国感染病学会官方声明：非结核分枝杆菌病的诊断、治疗与预防
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
4
Identification of Mycobacterium species by secA1 sequences.通过secA1序列鉴定分枝杆菌菌种。
J Clin Microbiol. 2005 Mar;43(3):1051-8. doi: 10.1128/JCM.43.3.1051-1058.2005.
5
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis.一种用于治疗结核病的小分子硝基咪唑并吡喃候选药物。
Nature. 2000 Jun 22;405(6789):962-6. doi: 10.1038/35016103.
6
Antimicrobial agents: pharmacology and clinical application in obstetric, gynecologic, and perinatal infections.
J Obstet Gynecol Neonatal Nurs. 1999 Nov-Dec;28(6):639-48. doi: 10.1111/j.1552-6909.1999.tb02173.x.
7
Helicobacter pylori: new developments and treatments.幽门螺杆菌：新进展与治疗方法
CMAJ. 1997 Jun 1;156(11):1565-74.
8
Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action.硝基咪唑类药物——作用机制与耐药机制。I. 作用机制
J Antimicrob Chemother. 1993 Jan;31(1):9-20. doi: 10.1093/jac/31.1.9.
9
Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis.甲硝唑对结核分枝杆菌的休眠细胞具有杀菌作用。
Antimicrob Agents Chemother. 1994 Sep;38(9):2054-8. doi: 10.1128/AAC.38.9.2054.
10
Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.幽门螺杆菌recA基因的分离及recA区域在耐低pH中的作用。
Infect Immun. 1995 Jun;63(6):2185-93. doi: 10.1128/iai.63.6.2185-2193.1995.

Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae.

作者信息

Mukherjee Tathagata, Boshoff Helena, Barry Clifton E

出版信息

J Antimicrob Chemother. 2012 Jan;67(1):252-3. doi: 10.1093/jac/dkr418. Epub 2011 Oct 7.

DOI:10.1093/jac/dkr418
PMID:21984744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3236054/
Abstract
摘要